Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 341,179 | 299,368 | 289,228 | 292,129 | 292,933 |
| Cost of Goods | 215,545 | 190,555 | 201,033 | 192,203 | 190,363 |
| Gross Profit | 125,634 | 108,813 | 88,195 | 99,926 | 102,570 |
| Operating Expenses | 75,154 | 69,662 | 63,621 | 59,286 | 59,745 |
| Operating Income | 51,025 | 39,706 | 24,607 | 40,843 | 43,188 |
| Interest Expense | 3,373 | 2,801 | 2,826 | 2,319 | 7,544 |
| Other Income | 2,889 | 6,081 | 1,325 | 4,202 | 1,203 |
| Pre-tax Income | 50,541 | 42,986 | 23,106 | 42,726 | 36,847 |
| Income Tax | 14,081 | 10,358 | 3,580 | 11,390 | 8,219 |
| Net Income Continuous | 36,460 | 32,628 | 19,526 | 31,336 | 28,628 |
| Net Income Discontinuous | -644 | -270 | -82 | -113 | -915 |
| Minority Interests | 552 | 126 | 345 | 356 | 429 |
| Net Income | $35,264 | $32,232 | $19,099 | $30,867 | $27,284 |
| EPS Basic Total Ops | 0.75 | 0.68 | 0.40 | 0.64 | 0.57 |
| EPS Basic Continuous Ops | 0.76 | 0.69 | 0.41 | 0.65 | 0.58 |
| EPS Basic Discontinuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Total Ops | 0.74 | 0.67 | 0.39 | 0.64 | 0.56 |
| EPS Diluted Continuous Ops | 0.75 | 0.67 | 0.40 | 0.64 | 0.58 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.02 |
| EBITDA(a) | $75,760 | $60,191 | $54,344 | $68,188 | $67,736 |